Glean's valuation, last formally set at $7.2 billion in its November 2025 Series F round led by Wellington Management, trades at approximately $6.9 billion on secondary markets as of early October 2026, reflecting a modest 4% decline amid broader private-market caution. The company has delivered robust fundamentals, with ARR reaching an estimated $300 million by May 2026 after 89% year-over-year growth from $208 million at year-end 2025, supported by expanding enterprise deployments and a roughly 24x revenue multiple that remains conservative relative to peers. With the October 31 resolution date now weeks away and no new priced round or major corporate event reported in the trailing 30 days, trader sentiment centers on whether secondary prints, potential late-stage funding activity, or macroeconomic shifts in AI spending could push the mark above the queried threshold before month-end.